⌘K

Login Start Free

Home/Filings/4/0001209191-20-009447

4//SEC Filing

Jaffe Matthias 4

Accession 0001209191-20-009447

CIK 0001664106other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 8:00 PM ET

Size

5.2 KB

Accession

0001209191-20-009447

Insider Transaction Report

Form 4

Period: 2020-02-11

LogicBio Therapeutics, Inc.LOGC

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2020-02-11+69,000→ 69,000 total
Exercise: $7.11Exp: 2030-02-11→ Common Stock (69,000 underlying)

Footnotes (1)

[F1]25% vests on 01/01/2021 and the remainder vests in equal monthly installments over the next 36 months.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

LogicBio Therapeutics, Inc.

CIK 0001664106

Entity typeother

Related Parties

1

filerCIK 0001752457

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 8:00 PM ET
Size: 5.2 KB

View on SEC.gov